Skip to main content
. 2017 Jul 10;2017:1315432. doi: 10.1155/2017/1315432

Table 2.

Comparison of clinical curative effect in the two groups after treatment at week 12 (n  (%)).

JieDuTongLuoShengJin granules + HCQ Placebo + HCQ p value
(between-group)
PASS, n (%)
 ESSPRI 19 (95.00) 12 (60.00) 0.024
MCII, n (%)
 ESSPRI 17 (85.00) 10 (50.00) 0.024
 ESSDAI 0 (0.00) 0 (0.00)